Zealand Pharma Logo

Zealand Pharma

Developing innovative peptide medicines for metabolic and inflammatory diseases.

ZEAL | CO

Overview

Corporate Details

ISIN(s):
DK0060257814 (+2 more)
LEI:
549300ITBB1ULBL4CZ12
Country:
Denmark
Address:
Sydmarken 11, 2860 Søborg
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zealand Pharma is a biotechnology company specializing in the discovery, design, and development of innovative peptide-based medicines. With over 25 years of expertise in peptide engineering, the company focuses on creating next-generation therapeutics for metabolic and inflammatory diseases. Its clinical pipeline targets conditions with significant unmet medical needs, including obesity, congenital hyperinsulinism, short bowel syndrome, and chronic autoimmune diseases. Key programs involve novel peptide analogs such as amylin, long-acting GLP-2, and dual agonists for GLP-1/GLP-2 and glucagon/GLP-1 receptors. The company advances its portfolio through both proprietary development and strategic partnerships with major pharmaceutical firms.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-17 17:05
Major Shareholding Notification
English 5.6 KB
2025-10-17 17:05
Major Shareholding Notification
English 553.9 KB
2025-10-17 17:05
Major Shareholding Notification
English 377.4 KB
2025-09-30 17:05
Declaration of Voting Results & Voting Rights Announcements
English 5.6 KB
2025-09-11 22:00
Share Issue/Capital Change
English 5.9 KB
2025-08-20 22:00
Major Shareholding Notification
English 5.6 KB
2025-08-20 22:00
Major Shareholding Notification
English 550.7 KB
2025-08-20 22:00
Major Shareholding Notification
English 367.5 KB
2025-08-14 07:00
Earnings Release
English 25.7 KB
2025-08-14 07:00
Earnings Release
English 891.1 KB
2025-07-18 18:30
Major Shareholding Notification
English 301.0 KB
2025-07-18 18:30
Major Shareholding Notification
English 5.6 KB
2025-07-18 18:30
Major Shareholding Notification
English 516.4 KB
2025-06-30 17:05
Declaration of Voting Results & Voting Rights Announcements
English 5.6 KB
2025-06-18 17:29
Regulatory News Service
English 14.1 KB

Automate Your Workflow. Get a real-time feed of all Zealand Pharma filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Zealand Pharma

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Zealand Pharma via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Entero Therapeutics, Inc. Logo
Develops targeted oral therapies for a range of gastrointestinal (GI) diseases.
United States of America ENTO
Entrada Therapeutics, Inc. Logo
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
United States of America TRDA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea 183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea 446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden EQL
Equillium, Inc. Logo
Clinical-stage biotech creating therapies for severe autoimmune and inflammatory disorders.
United States of America EQ
Erasca, Inc. Logo
Clinical-stage oncology company developing therapies targeting the RAS/MAPK pathway in cancer.
United States of America ERAS
Ernexa Therapeutics Inc. Logo
Developing targeted, off-the-shelf cell therapies for cancer and autoimmune diseases.
United States of America ERNA
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France ERYP

Talk to a Data Expert

Have a question? We'll get back to you promptly.